DRG Epidemiology's coverage of osteoporosis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of osteoporosis for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan, and 10 years for the other countries covered in this report.

DRG Epidemiology's osteoporosis will answer the following questions:

  • Of all people with osteoporosis, how many in each country across the major mature pharmaceutical markets have been formally diagnosed?
  • Of all people diagnosed with osteoporosis, how many in each country across the major mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of osteoporosis over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In addition to the total number of cases for each forecast year, DRG Epidemiology also provides at least ten years of forecast data for the following osteoporosis subpopulations:

  • Total prevalent cases by diagnosis status.
  • Diagnosed prevalent cases by drug treatment status.

Note: Coverage may vary by country.

Table of contents

  • Epidemiology Dashboard
    • Introduction
      • Introduction
      • Osteoporosis Epidemiology Dashboard

Author(s): Devashri Mukherjee, MPH

Research enthusiast with a flair for academic writing, member of the DRG family since April 2015 and working from the India office. Started off career with a bachelor’s in Dental Surgery followed by a master’s in Public health; having primarily worked in the hospital setting as a Research Consultant prior to DRG and with 10 international publications to my credit.


Related Reports

Osteoporosis | Landscape & Forecast | Disease Landscape & Forecast

With an increasing prevalence, due to aging populations, the major-market osteoporosis patient pool is large and growing. The combined influence of increased patient numbers and drug launches wil...

View Details

Osteoporosis | Unmet Need | Detailed, Expanded Analysis (US/EU)

Patients with osteoporosis have an increased risk of fractures owing to a loss in bone strength. A significant unmet need exists for treatment that is more effective than current therapies and we...

View Details

Osteoporosis | Epidemiology | Extrapolated Worldwide Coverage

DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key osteoporosis patient p...

View Details

Osteoporosis | Epidemiology | Americas

DRG Epidemiology’s coverage of osteoporosis comprises epidemiological estimates of key patient populations in 14 mature and emerging pharmaceut...

View Details